OncoTargets and Therapy (Oct 2019)
Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum]
Abstract
Shen D, Wang H, Zheng Q, et al. Onco Targets Ther. 2019;12:7877–7886. Upon reviewing the article, the authors noticed an error in two of the authors name (page 7877). The correct author ames are Liqun Xia and Gonghui Li. The authors apologize for this error. Read the original article